Page last updated: 2024-09-04

moxifloxacin and Sinusitis

moxifloxacin has been researched along with Sinusitis in 26 studies

Research

Studies (26)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	20 (76.92)	29.6817
2010's	6 (23.08)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Keating, KN; Lloyd, A; Nafees, B; Piccirillo, J; Quadri, N; Wild, D	1
Arvis, P; Desrosiers, M; Heldner, S; Mösges, R	1
Edzhe, MA; Hon, EM; Korostelev, SA; Miroshnichenko, NA; Ovchinnikov, AY	1
Decramer, M; Simoens, S	1
Anzueto, A; Miravitlles, M	1
Fox, M; Kovacic, D; Reichenberg, J	1
Hu, B; Jiang, X; Liang, C; Ruan, B; Wang, H; Wang, J; Xiao, G; Xiao, S; Ye, Q; Zhai, L; Zhou, B	1
Desrosiers, M; Hadley, JA; Haverstock, D; Herman-Gnjidic, Z; Mösges, R; van Veenhuyzen, D	1
Chapuzet, C; Duncombe, A; Gueit, I; Gueudry, J; Massy, N; Muraine, M	1
Egorov, VI; Kozarenko, AV	1
Iakovlev, VP; Polushkina, NR	1
Dinis, PB; Martins, ML; Monteiro, MC; Morais, JG; Silva, N	1
Choudhri, S; Cihon, C; Herrington, J; Johnson, P	1
Ferguson, BJ; Guzzetta, RV; Hadley, JA; Spector, SL	1
Keating, GM; Scott, LJ	1
Anon, JB	1
Friedman, HS; Keating, KN; Perfetto, EM	1
Blair, C; Kirtsreesakul, V; Luxameechanporn, T; Naclerio, RM; Thompson, K	1
De Benedetto, L; De Benedetto, M; Passali, D; Passali, GC; Salerni, L	1
Dimopoulos, G; Falagas, ME; Giannopoulou, KP; Grammatikos, AP; Karageorgopoulos, DE	1
Bagger-Sjöbäck, D; Gehanno, P; Hampel, B; Ibanez, JM; Nikolaidis, P; Siegert, R; Sommerauer, B	1
Kirch, W; Siepmann, M	1
Garau, J; Lode, H	1
Arvis, P; Bobin, F; Bobin, S; Chobaut, JC; Darantière, S; Dubreuil, C; Gehanno, P; Pages, JC; Renou, G; Stass, H	1

Reviews

11 review(s) available for moxifloxacin and Sinusitis

Article	Year
[15-year experience of moxifloxacin in the treatment of patients with bacterial rhinosinusitis]. Vestnik otorinolaringologii, 2015, Volume: 80, Issue:3 Topics: Acute Disease; Anti-Bacterial Agents; Bacterial Infections; Fluoroquinolones; Humans; Moxifloxacin; Rhinitis; Russia; Sinusitis; Treatment Outcome	2015
A pharmacoeconomic review of the management of respiratory tract infections with moxifloxacin. Expert opinion on pharmacotherapy, 2008, Volume: 9, Issue:10 Topics: Anti-Infective Agents; Aza Compounds; Bronchitis, Chronic; Community-Acquired Infections; Costs and Cost Analysis; Fluoroquinolones; Humans; Moxifloxacin; Pneumonia, Bacterial; Quinolines; Respiratory Tract Infections; Sinusitis	2008
Moxifloxacin: a respiratory fluoroquinolone. Expert opinion on pharmacotherapy, 2008, Volume: 9, Issue:10 Topics: Anti-Bacterial Agents; Aza Compounds; Bronchitis, Chronic; Clinical Trials as Topic; Community-Acquired Infections; Fluoroquinolones; Humans; Moxifloxacin; Pneumonia, Bacterial; Quinolines; Respiratory Tract Infections; Sinusitis	2008
[Moxifloxacin: results of clinical use]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2002, Volume: 47, Issue:10 Topics: Anti-Infective Agents; Aza Compounds; Bronchitis, Chronic; Clinical Trials as Topic; Fluoroquinolones; Humans; Moxifloxacin; Pneumonia; Quinolines; Respiratory Tract Infections; Sinusitis; Skin Diseases, Bacterial; Treatment Outcome	2002
Efficacy and tolerability of moxifloxacin in the treatment of acute bacterial sinusitis caused by penicillin-resistant Streptococcus pneumoniae: a pooled analysis. Clinical therapeutics, 2004, Volume: 26, Issue:2 Topics: Acute Disease; Adult; Aza Compounds; Drug Tolerance; Female; Fluoroquinolones; Humans; Male; Moxifloxacin; Penicillin Resistance; Pneumococcal Infections; Quinolines; Severity of Illness Index; Sinusitis; Streptococcus pneumoniae	2004
Moxifloxacin--a new fluoroquinolone antibacterial. Drug and therapeutics bulletin, 2004, Volume: 42, Issue:8 Topics: Anti-Bacterial Agents; Aza Compounds; Drug Administration Schedule; Drug Costs; Fluoroquinolones; Humans; Moxifloxacin; Pneumonia; Quinolines; Randomized Controlled Trials as Topic; Respiratory Tract Diseases; Sinusitis	2004
Moxifloxacin: a review of its use in the management of bacterial infections. Drugs, 2004, Volume: 64, Issue:20 Topics: Anti-Bacterial Agents; Area Under Curve; Aza Compounds; Biological Availability; Bronchitis, Chronic; Clinical Trials as Topic; Community-Acquired Infections; Fluoroquinolones; Half-Life; Humans; Intestinal Absorption; Microbial Sensitivity Tests; Moxifloxacin; Pneumonia; Quinolines; Sinusitis; Tissue Distribution; Topoisomerase II Inhibitors	2004
Current management of acute bacterial rhinosinusitis and the role of moxifloxacin. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, Jul-15, Volume: 41 Suppl 2 Topics: Anti-Bacterial Agents; Aza Compounds; Bacterial Infections; Clinical Trials as Topic; Drug Resistance, Microbial; Fluoroquinolones; Gatifloxacin; Haemophilus influenzae; Humans; Levofloxacin; Meta-Analysis as Topic; Moxifloxacin; Ofloxacin; Practice Guidelines as Topic; Quinolines; Rhinitis; Sinusitis; Streptococcus pneumoniae	2005
[Rhinosinusitis: etiopathogenesis and antimicrobial therapy, an update]. Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale, 2006, Volume: 26, Issue:1 Suppl 82 Topics: Administration, Oral; Adrenal Cortex Hormones; Adult; Anti-Bacterial Agents; Aza Compounds; Bacteria; Child; Drug Resistance, Microbial; Endoscopy; Fluoroquinolones; Humans; Moxifloxacin; Mucociliary Clearance; Nasal Decongestants; Ofloxacin; Prevalence; Quinolines; Recurrence; Retrospective Studies; Risk; Sinusitis; Time Factors; Tomography, X-Ray Computed	2006
Fluoroquinolones compared with beta-lactam antibiotics for the treatment of acute bacterial sinusitis: a meta-analysis of randomized controlled trials. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2008, Mar-25, Volume: 178, Issue:7 Topics: Acute Disease; Anti-Bacterial Agents; Aza Compounds; beta-Lactams; Fluoroquinolones; Humans; Moxifloxacin; Pneumococcal Infections; Quinolines; Randomized Controlled Trials as Topic; Sinusitis	2008
Improving care for patients with respiratory tract infections. Journal of chemotherapy (Florence, Italy), 2002, Volume: 14 Suppl 2 Topics: Anti-Infective Agents; Aza Compounds; Bronchitis; Chronic Disease; Clinical Trials as Topic; Community-Acquired Infections; Fluoroquinolones; Humans; Moxifloxacin; Patient Satisfaction; Pneumonia; Quality of Health Care; Quinolines; Sinusitis	2002

Trials

8 trial(s) available for moxifloxacin and Sinusitis

Article	Year
Psychometric evaluation of the Sinonasal Outcome Test-16 and activity impairment assessment in acute bacterial sinusitis. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2013, Volume: 149, Issue:1 Topics: Activities of Daily Living; Adult; Anti-Bacterial Agents; Aza Compounds; Bacterial Infections; Cohort Studies; Disability Evaluation; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Outcome Assessment, Health Care; Psychometrics; Quinolines; Recovery of Function; Reproducibility of Results; Self Report; Sinusitis	2013
Characterisation of patients receiving moxifloxacin for acute bacterial rhinosinusitis in clinical practice: results from an international, observational cohort study. PloS one, 2013, Volume: 8, Issue:4 Topics: Activities of Daily Living; Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Asia; Aza Compounds; Child; Child, Preschool; Europe; Female; Fluoroquinolones; Humans; Infant; Male; Middle Aged; Middle East; Moxifloxacin; Prospective Studies; Quinolines; Rhinitis; Sinusitis; Sleep; Treatment Outcome	2013
Moxifloxacin in the treatment of acute bacterial rhinosinusitis: results of a multicenter, non-interventional study. Acta oto-laryngologica, 2010, Volume: 130, Issue:9 Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Aza Compounds; Bacterial Infections; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Product Surveillance, Postmarketing; Prospective Studies; Quinolines; Rhinitis; Sinusitis; Treatment Outcome; Young Adult	2010
Moxifloxacin five-day therapy versus placebo in acute bacterial rhinosinusitis. The Laryngoscope, 2010, Volume: 120, Issue:5 Topics: Administration, Oral; Adult; Anti-Infective Agents; Aza Compounds; Bacterial Infections; Double-Blind Method; Drug Administration Schedule; Female; Fluoroquinolones; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Patient Dropouts; Quinolines; Rhinitis; Sinusitis; Treatment Outcome	2010
Sinus tissue concentration of moxifloxacin after a single oral dose. The Annals of otology, rhinology, and laryngology, 2004, Volume: 113, Issue:2 Topics: Administration, Oral; Adult; Age Factors; Aged; Anti-Infective Agents; Aza Compounds; Chronic Disease; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Nasal Mucosa; Paranasal Sinuses; Quinolines; Rhinitis; Sinusitis	2004
Efficacy and safety of oral telithromycin once daily for 5 days versus moxifloxacin once daily for 10 days in the treatment of acute bacterial rhinosinusitis. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2004, Volume: 131, Issue:3 Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Aza Compounds; Bacterial Infections; Double-Blind Method; Drug Administration Schedule; Female; Fluoroquinolones; Humans; Ketolides; Macrolides; Male; Middle Aged; Moxifloxacin; Prospective Studies; Quinolines; Rhinitis; Sinusitis; Time Factors	2004
A comparison of the safety and efficacy of moxifloxacin (BAY 12-8039) and cefuroxime axetil in the treatment of acute bacterial sinusitis in adults. The Sinusitis Study Group. Respiratory medicine, 2000, Volume: 94, Issue:4 Topics: Acute Disease; Adult; Anti-Infective Agents; Aza Compounds; Bacterial Infections; Cefuroxime; Cephalosporins; Double-Blind Method; Drug Evaluation; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Prospective Studies; Quinolines; Sinusitis	2000
A prospective, multicentre study of moxifloxacin concentrations in the sinus mucosa tissue of patients undergoing elective surgery of the sinus. The Journal of antimicrobial chemotherapy, 2002, Volume: 49, Issue:5 Topics: Adult; Anti-Infective Agents; Aza Compounds; Double-Blind Method; Elective Surgical Procedures; Ethmoid Sinus; Female; Fluoroquinolones; Humans; Male; Maxillary Sinus; Moxifloxacin; Nasal Polyps; Paranasal Sinuses; Quinolines; Sinusitis	2002

Other Studies

7 other study(ies) available for moxifloxacin and Sinusitis

Article	Year
Moxifloxacin as the likely cause of drug-induced linear immunoglobulin A bullous dermatosis. Journal of drugs in dermatology : JDD, 2008, Volume: 7, Issue:8 Topics: Aged; Anti-Bacterial Agents; Aza Compounds; Drug Eruptions; Fluoroquinolones; Humans; Immunoglobulin A; Male; Moxifloxacin; Quinolines; Sinusitis; Skin; Skin Diseases, Vesiculobullous	2008
Moxifloxacin: new indication. Inadequate restriction of indications in ENT and respiratory infections. Prescrire international, 2009, Volume: 18, Issue:103 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Bronchitis; Chemical and Drug Induced Liver Injury; Europe; Fluoroquinolones; Humans; Long QT Syndrome; Moxifloxacin; Pneumococcal Infections; Quinolines; Respiratory Tract Infections; Safety-Based Drug Withdrawals; Sinusitis; Stevens-Johnson Syndrome	2009
[Severe pseudouveitis associated with moxifloxacin therapy]. Journal francais d'ophtalmologie, 2013, Volume: 36, Issue:2 Topics: Anti-Bacterial Agents; Aza Compounds; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Quinolines; Respiratory Tract Infections; Severity of Illness Index; Sinusitis; Uveitis	2013
[Effectiveness of a new fluoroquinolone antibiotic avelox in the treatment of suppurative sinusitis]. Vestnik otorinolaringologii, 2002, Issue:5 Topics: Acute Disease; Adolescent; Adult; Anti-Infective Agents; Aza Compounds; Female; Fluoroquinolones; Frontal Sinusitis; Humans; Male; Maxillary Sinusitis; Middle Aged; Moxifloxacin; Quinolines; Sinusitis; Suppuration; Time Factors	2002
Moxifloxacin versus levofloxacin for treatment of acute rhinosinusitis: a retrospective database analysis of treatment duration, outcomes, and charges. Current medical research and opinion, 2006, Volume: 22, Issue:2 Topics: Acute Disease; Adult; Anti-Bacterial Agents; Aza Compounds; Database Management Systems; Female; Fluoroquinolones; Humans; Levofloxacin; Male; Middle Aged; Moxifloxacin; Ofloxacin; Quinolines; Retrospective Studies; Sinusitis; Treatment Outcome; United States	2006
The effect of treatment with moxifloxacin or azithromycin on acute bacterial rhinosinusitis in mice. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2006, Volume: 10, Issue:5 Topics: Acute Disease; Animals; Anti-Bacterial Agents; Aza Compounds; Azithromycin; CD11b Antigen; CD4 Antigens; CD8 Antigens; Disease Models, Animal; Female; Fluoroquinolones; Male; Mice; Mice, Inbred C57BL; Moxifloxacin; Pneumococcal Infections; Quinolines; Rhinitis; Sinusitis; Streptococcus pneumoniae	2006
Drug Points: tachycardia associated with moxifloxacin. BMJ (Clinical research ed.), 2001, Jan-06, Volume: 322, Issue:7277 Topics: Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Aza Compounds; Bronchitis; Fluoroquinolones; Headache; Humans; Male; Middle Aged; Moxifloxacin; Quinolines; Sinusitis; Tachycardia	2001